Skip to main content
Premium Trial:

Request an Annual Quote

Maybe Someday, But Maybe Not

In an essay at Nature, Oregon Health and Science University's Vinay Prasad argues that precision medicine for cancer is largely an 'illusion' despite high hopes for such treatment. Few patients, he says, have benefitted so far from a precision medicine approach.

According to Prasad, two sequencing efforts aimed at matching cancer patients to therapies based on their tumors' genetic profiles have only been able to pair a portion of patients — 6.4 percent for MD Anderson Cancer Center and 2 percent for NCI-MATCH — with treatments.

Part of the issue there, notes Derek Lowe at In the Pipeline, is that there just aren't that many tailored drugs. Further, Prasad adds that only a portion of patients have had an exceptional response to such treatment.

"In the big oncology picture, there aren't many of those at all, so for most patients (arguably 'nearly all patients') there really isn't a targeted therapy to offer," Lowe writes.

Another issue Prasad raises is that there has been only one randomized controlled trial of precision medicine in oncology, the SHIVA trial. And it, he says, found reported a median progression-free survival of 2.3 months and 2.0 months, respectively, for patients whose treatment was guided by their genetic profile and for patients given the treatment recommended by their doctors. Additional studies, he says, are needed.

"Precision oncology is inspirational. What doctor or patient would not want to harness genetics to tailor a therapy to an individual?" Prasad writes. "But traveling back in a time machine is also inspirational."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.